The study at Georgetown University Medical Centre in the US suggests an urgent need for human epidemiological and basic research that examines the link between maternal cannabinoid use, either smoked or eaten in candy bars, and the health of newborns.
Cannabinoids are chemicals like THC, the primary psychoactive compound in marijuana, that act on cannabinoid receptors in neurons, repressing the normal release of neurotransmitters.
"We know from limited human studies that use of marijuana in early pregnancy is associated with many of the same risks as tobacco, including miscarriage, birth defects, developmental delays and learning disabilities, but animal research suggests the potential for many more developmental issues linked with the drug," said G Ian Gallicano, associate professor at Georgetown.
"All of the model systems point to the notion that cannabinoids affects many aspects of human development because THC and other chemicals alter molecular pathways that shouldn't be disrupted during development of a foetus," he said.
"We also know that THC is a promising agent for treating cancer, because it negatively affects tumour growth and can cause the death of cancer cells," he added.
"Embryo development has similarities to tumour formation - it turns on growth pathways that are necessary for development," Gallicano said.
Researchers reviewed the scientific literature for studies on cannabinoids and embryonic development published between 1975 and 2015.
They found that THC lasts in the body for weeks, especially in maternal tissues that act as reservoirs for THC and other cannabinoids, according to studies of pregnant dogs.
Human cells studies have shown that THC has a half-life of eight days in fat deposits and can be detected in blood for up to 30 days, they said.
Another study showed that THC readily crosses the human placenta, which can slow clearance of the drugs while prolonging foetal exposure.
THC and other cannabinoids interfere with use of folic acid (vitamin B9), which has long been known to be essential for normal development and growth of the human placenta and embryo.
Deficiencies in folic acid are linked to low human birth weight, increased risk of spontaneous abortion, and neural tube defects.
Cannabinoid signalling plays important roles in development of a mouse embryo. It is required for proper pre-implantation development, embryo transport to the uterus, and implantation.
The research was published in the journal BioMed Central (BMC) Pharmacology and Toxicology.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
